Frog Protein Protects Mice From Shellfish Poisoning

Researchers have discovered that a protein derived from bullfrogs can act as an antidote to deadly shellfish poisoning in mice, according to a report by Science News published August 5, 2026. The protein targets the toxins responsible for paralytic shellfish poisoning, potentially providing a new pathway for treating humans affected by these neurotoxins.

Bullfrog proteins neutralize shellfish neurotoxins

The study involved injecting mice with a specific protein sourced from bullfrogs to determine if it could counteract the effects of shellfish poisoning. According to Science News, the treatment successfully saved the mice from the toxins that typically cause respiratory failure and death in mammals.

Shellfish poisoning occurs when humans consume bivalves, such as mussels or clams, that have accumulated toxins produced by certain algae. These toxins block sodium channels in the nervous system, which prevents muscles from contracting and can lead to paralysis.

Mechanism of the frog-derived antidote

The antidote works by interfering with the way shellfish toxins bind to nerve cells. While the toxins typically lock onto sodium channels to shut down electrical signaling, the bullfrog protein prevents this binding or reverses the blockage, according to the research detailed by Science News.

This biological mechanism is significant because there is currently no direct antidote for paralytic shellfish poisoning in humans. Standard medical care focuses on supportive therapy, which primarily involves mechanical ventilation to keep patients breathing until the toxins naturally clear from the body.

Context of paralytic shellfish poisoning

Paralytic shellfish poisoning is caused by saxitoxins and related compounds. These toxins are produced by dinoflagellates, a type of plankton that can bloom in large numbers during “red tides.” When shellfish filter-feed on these plankton, they concentrate the toxins in their tissues.

Symptoms in humans typically begin with tingling or numbness in the lips and tongue, progressing to muscle weakness and, in severe cases, complete respiratory paralysis. Because the toxins act rapidly on the peripheral nervous system, immediate medical intervention is required to prevent fatality.

Current limitations and future research

The findings are currently limited to animal models. Science News reports that while the bullfrog protein saved mice, further research is required to determine if the treatment is safe and effective for human use.

Potential hurdles for human application include the risk of an immune response to the frog-derived protein and the need to determine an effective dosage for humans. Researchers must also establish whether the protein can be synthesized in a lab to ensure purity and scalability for clinical use.